The first wave of COVID-19 in Intensive care
In December 2019, in Wuhan, a new human infectious pathology was born, COVID-19, consisting above all in pneumoniae, induced by the coronavirus named SARS-CoV-2 because of the respiratory distress it caused (SARS for severe acute respiratory syndrome, and CoV for Coronavirus). A real health and planetary crisis has appeared, much more substantial than that linked to SARS-CoV-1 in 2002-2004 and to MERS-CoV (Middle East Respiratory Syndrome Coronavirus) in 2012. In addition to respiratory damage that can be dramatic, this pathology is complicated by the frequency of cardiovascular, renal and coagulation diseases. Health care systems have had to adapt urgently, in the absence of hindsight from the pathology, and without effective therapeutic weapons. Through this review of the literature, we detail our local practices for the overall management of patients hospitalized in Intensive care.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:75 |
|---|---|
| Enthalten in: |
Revue medicale de Liege - 75(2020), S1 vom: 21., Seite 18-28 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
La première vague de la COVID-19 aux Soins intensifs, mars-mai 2020 |
|---|
| Beteiligte Personen: |
Marchetta, S [VerfasserIn] |
|---|
| Themen: |
ARDS |
|---|
| Anmerkungen: |
Date Completed 23.11.2020 Date Revised 18.12.2020 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM317785559 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317785559 | ||
| 003 | DE-627 | ||
| 005 | 20231225164008.0 | ||
| 007 | tu | ||
| 008 | 231225s2020 xx ||||| 00| ||fre c | ||
| 028 | 5 | 2 | |a pubmed24n1059.xml |
| 035 | |a (DE-627)NLM317785559 | ||
| 035 | |a (NLM)33211418 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Marchetta, S |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The first wave of COVID-19 in Intensive care |
| 246 | 3 | 3 | |a La première vague de la COVID-19 aux Soins intensifs, mars-mai 2020 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 23.11.2020 | ||
| 500 | |a Date Revised 18.12.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a In December 2019, in Wuhan, a new human infectious pathology was born, COVID-19, consisting above all in pneumoniae, induced by the coronavirus named SARS-CoV-2 because of the respiratory distress it caused (SARS for severe acute respiratory syndrome, and CoV for Coronavirus). A real health and planetary crisis has appeared, much more substantial than that linked to SARS-CoV-1 in 2002-2004 and to MERS-CoV (Middle East Respiratory Syndrome Coronavirus) in 2012. In addition to respiratory damage that can be dramatic, this pathology is complicated by the frequency of cardiovascular, renal and coagulation diseases. Health care systems have had to adapt urgently, in the absence of hindsight from the pathology, and without effective therapeutic weapons. Through this review of the literature, we detail our local practices for the overall management of patients hospitalized in Intensive care | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a ARDS | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Complications | |
| 650 | 4 | |a Drug therapy | |
| 650 | 4 | |a Intensive care | |
| 650 | 4 | |a Invasive ventilation | |
| 650 | 4 | |a Multiorgan failure | |
| 700 | 1 | |a Lambermont, B |e verfasserin |4 aut | |
| 700 | 1 | |a Massion, P |e verfasserin |4 aut | |
| 700 | 1 | |a Rousseau, A F |e verfasserin |4 aut | |
| 700 | 1 | |a Layios, N |e verfasserin |4 aut | |
| 700 | 1 | |a Robinet, S |e verfasserin |4 aut | |
| 700 | 1 | |a Canivet, J L |e verfasserin |4 aut | |
| 700 | 1 | |a Kisoka, G |e verfasserin |4 aut | |
| 700 | 1 | |a Ledoux, D |e verfasserin |4 aut | |
| 700 | 1 | |a Morimont, P |e verfasserin |4 aut | |
| 700 | 1 | |a Piret, S |e verfasserin |4 aut | |
| 700 | 1 | |a Wiesen, P |e verfasserin |4 aut | |
| 700 | 1 | |a Misset, B |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revue medicale de Liege |d 1947 |g 75(2020), S1 vom: 21., Seite 18-28 |w (DE-627)NLM000044490 |x 0370-629X |7 nnns |
| 773 | 1 | 8 | |g volume:75 |g year:2020 |g number:S1 |g day:21 |g pages:18-28 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 75 |j 2020 |e S1 |b 21 |h 18-28 | ||